Infections
|
March 11, 2025

Sporotrichosis: Causes & Treatments

Written By
Medically Reviewed by
Updated On
April 2, 2025

A simple scratch from a thorn or a small cut while gardening might seem harmless. But in some cases, these minor wounds can lead to a fungal infection called sporotrichosis. This infection, caused by the fungus Sporothrix schenckii, often starts in the skin but can spread to other parts of the body if left untreated.

This article will guide you through the causes, symptoms, diagnosis, treatment options, and prevention strategies for sporotrichosis. Whether you're a medical professional, a researcher, or someone looking for answers about an unusual skin infection, you'll find the information you need to stay informed and protected.

[signup]

What is Sporotrichosis?

This infection primarily affects the skin but can spread to other parts of the body in severe cases. It is often referred to as "rose gardener’s disease” due to its association with plant handling and soil exposure. Sporotrichosis is considered a zoonotic disease, as it can also be transmitted through infected animals, particularly cats.

Causative Agent: Sporothrix schenckii

Sporothrix schenckii is a dimorphic fungus, meaning it can exist in two different forms depending on temperature. In the environment, it remains in a mold form, producing spores that can enter the skin through minor cuts or puncture wounds. This fungus is commonly found in soil, sphagnum moss, hay, and plant material, making gardeners, farmers, and outdoor workers more susceptible to infection.

Types of Sporotrichosis

Sporotrichosis manifests in different forms depending on the route of infection and the individual’s immune status:

  • Cutaneous (Skin) Sporotrichosis: The most common form, occurring when the fungus enters through a skin wound. It typically causes ulcerated nodules along lymphatic pathways.
  • Lymphocutaneous Sporotrichosis: A more advanced stage of cutaneous sporotrichosis where the infection spreads along lymphatic channels, forming a chain of lesions.
  • Systemic (Disseminated) Sporotrichosis: A rare but severe form where the infection spreads to internal organs, bones, joints, or the central nervous system. This form is more likely to affect immunocompromised individuals, such as those with HIV/AIDS or undergoing immunosuppressive therapy.

Epidemiology

Sporotrichosis occurs worldwide but is more prevalent in certain regions with favorable environmental conditions. It primarily affects individuals who work with soil, plants, or animals, with some populations being at higher risk due to occupational or geographic factors.

Global Distribution

While sporotrichosis has been reported globally, it is most commonly found in tropical and subtropical regions, particularly in Latin America, Africa, and parts of Asia. Countries such as Brazil, Mexico, and China have reported significant outbreaks, often linked to environmental exposure or zoonotic transmission through infected animals. 

Cases have also been documented in the United States, especially in regions with high agricultural activity.

High-Risk Areas and Populations

Certain groups are at a higher risk of contracting sporotrichosis due to their frequent exposure to soil, plants, and animals. These include:

  • Gardeners, farmers, and florists: Individuals handling plants and soil are more susceptible to cutaneous sporotrichosis.
  • Veterinarians and Pet Owners: People in close contact with infected animals, particularly cats, can contract zoonotic sporotrichosis through bites or scratches.
  • Immunocompromised Individuals: Those with weakened immune systems, such as HIV/AIDS patients or individuals undergoing immunosuppressive therapy, are at greater risk for systemic infection.

Causes and Transmission

Sporotrichosis is caused by the fungus Sporothrix schenckii, which lives in soil, plants, and decaying organic matter. The infection occurs when fungal spores enter the body through small cuts or scratches. In some cases, the disease can also spread from infected animals. Understanding how sporotrichosis spreads and who is most at risk can help prevent infections.

How Sporotrichosis Spreads

Sporotrichosis spreads through contact with contaminated soil, plants, or infected animals. The most common way people get infected is through environmental exposure. The infection happens when fungal spores from soil, decaying wood, or plants like roses and moss enter the skin through small cuts or scratches. 

Gardeners, farmers, and hikers are at a higher risk due to this, especially in warm, humid regions where the fungus thrives. A minor scratch, cut, or puncture wound can allow the fungus to enter the skin, leading to infection. Since Sporothrix schenckii thrives in warm, humid environments, cases are more frequent in tropical and subtropical regions.

Zoonotic Transmission (Animals)

The disease can also spread from animals, particularly cats, making it a zoonotic infection. Infected cats can carry high levels of the fungus in their skin lesions. Humans can catch it through scratches, bites, or by handling contaminated bedding or wounds without protective gloves. 

This form of transmission has caused outbreaks in some areas, especially in Brazil, putting veterinarians and animal caregivers at higher risk.

Risk Factors

Certain groups are more vulnerable to severe sporotrichosis, including people with weakened immune systems, such as those with HIV/AIDS, diabetes, or those undergoing chemotherapy. Early diagnosis and treatment are crucial, especially for these high-risk individuals. 

By understanding how sporotrichosis spreads and who is most at risk, people can take preventive measures to reduce the chance of infection. For these individuals, a mild skin infection could progress to a more serious form affecting the lungs, bones, or even the brain. 

Early detection and treatment are essential. Understanding how sporotrichosis spreads and who is most at risk can help with prevention and early intervention, reducing the impact of this fungal infection.

Symptoms and Diagnosis

Early recognition of sporotrichosis symptoms is essential for timely diagnosis and treatment. The infection typically starts in the skin but can spread to deeper tissues or even internal organs in severe cases. Diagnosing sporotrichosis involves laboratory tests, imaging techniques, and ruling out other conditions with similar symptoms.

Recognizing Sporotrichosis Symptoms

Sporotrichosis symptoms vary depending on the type of infection. The disease most commonly affects the skin (cutaneous form), but in rare cases, it can spread to other organs (systemic form).

Cutaneous Symptoms

The skin form of sporotrichosis is the most common and usually develops after fungal spores enter through a cut or scratch. Symptoms include:

  • Small, painless bumps that appear at the site of infection, often on the hands, arms, or legs.
  • Lesions grow and ulcerate, developing an open sore with a red or purple border.
  • The cells slowly spread along lymphatic channels, forming a chain of nodules.
  • Minimal pain unless secondary infections occur.

Without treatment, the sores can persist for months or even years.

Systemic Symptoms

Systemic sporotrichosis is rare but can be severe, especially in immunocompromised individuals. It occurs when the infection spreads beyond the skin to deeper tissues or organs, leading to:

Diagnostic Methods

Proper diagnosis of sporotrichosis is crucial because its symptoms can look like other skin conditions. Laboratory tests are the most reliable way to confirm the infection.

Laboratory Tests (Culture, Microscopy)

A fungal culture is the most accurate way to find Sporothrix schenckii. This is done by growing a sample from a skin lesion, sputum, or tissue biopsy on a special medium. Direct microscopy involves examining a stained sample under a microscope to detect fungal cells. In some cases, serological tests can detect antibodies against the fungus, but they are less commonly used.

Imaging Techniques

If the infection spreads to the lungs, chest X-rays or CT scans can reveal lung abnormalities. For joint or bone involvement, MRIs or bone scans help assess the extent of the infection.

Differential Diagnosis

Because sporotrichosis can look like other conditions, doctors have to rule out other options. These include skin cancers or inflammatory skin diseases, bacterial infections like tuberculosis, and fungal infections like blastomycosis. Accurate diagnosis ensures the right treatment and better outcomes.

Treatment Options

Sporotrichosis is treatable, but the approach depends on the severity of the infection and the patient’s overall health. Most cases respond well to antifungal medications, while more severe infections may require additional therapies. Proper wound care and management of complications also play a key role in recovery.

Antifungal Medications

Antifungal medications are the main treatment for sporotrichosis, with the duration depending on the infection's severity.

First-line Treatments (Itraconazole)

Itraconazole is the preferred antifungal, especially for cutaneous and lymphocutaneous forms. It is taken orally, with treatment typically lasting 3 to 6 months, though severe cases may need longer. Most patients tolerate itraconazole well, but mild side effects like nausea or headaches can occur.

Alternative Treatments (Terbinafine, Amphotericin B)

Terbinafine is an alternative for mild-to-moderate cases. Amphotericin B is reserved for severe or systemic infections, given intravenously (IV) in hospitals. Once symptoms improve, patients may switch to long-term itraconazole therapy. These alternatives are used if itraconazole is ineffective or not tolerated.

Supportive Therapies

Keeping affected skin areas clean and dry prevents secondary infections. Antiseptic solutions and, in some cases, topical antifungals may be recommended for sporotrichosis treatment.

Managing Complications

Pain relief with over-the-counter medications like ibuprofen can help with discomfort from sporotrichosis. In rare cases, surgical drainage of large lesions is needed. Patients with systemic infections require regular check-ups to monitor for complications.

Treatment in Special Populations

Itraconazole is the preferred treatment for children, with doses adjusted based on weight. In severe cases of sporotrichosis, Amphotericin B may be used under hospital supervision. Children often need longer treatment durations and close monitoring for side effects.

Treatment for Immunocompromised Patients

People with HIV/AIDS, cancer, or on immunosuppressive therapy are at higher risk for severe sporotrichosis. They may require Amphotericin B followed by long-term maintenance with itraconazole. In severe cases, lifelong suppression therapy may be needed to prevent recurrence.

Early diagnosis and treatment improve outcomes, so individuals with persistent skin lesions or unexplained symptoms should see a healthcare provider.

Prevention and Public Health

Sporotrichosis is preventable with proper precautions, especially for those at higher risk, such as gardeners, farmers, and veterinarians. Public health strategies, including education and surveillance, also play a vital role in controlling outbreaks and reducing the spread of infection.

Preventive Measures

Reducing exposure to Sporothrix schenckii is key to preventing sporotrichosis. Personal protective equipment and environmental controls can help minimize the risk of infection.

Personal Protective Equipment (PPE)

Wearing protective gear when handling soil, plants, or animals can help prevent fungal spores from entering the body through cuts or scratches. Recommended precautions include:

  • Gloves: Wear thick, protective gloves when gardening, farming, or handling plants like roses and moss.
  • Long sleeves and pants: Reduce skin exposure when working in environments where the fungus may be present.
  • Face masks: For those at risk of inhaling fungal spores (e.g., working with contaminated soil or in veterinary settings).

Veterinarians and animal caregivers should use gloves and protective clothing when treating animals suspected of having sporotrichosis, particularly cats.

Environmental Controls

Limiting exposure to fungal sources can further reduce the risk of sporotrichosis.

  • Proper handling of soil and plants: Avoid direct skin contact with thorny plants, hay, or decaying wood.
  • Safe disposal of contaminated materials: Infected animal waste and bedding should be handled with care and properly disposed of.
  • Control of stray animal populations: Reducing stray cat populations in endemic areas can help prevent zoonotic transmission.

Public Health Strategies

Public health initiatives focus on raising awareness, improving surveillance, and ensuring timely diagnosis and treatment to prevent widespread infections.

Education and Awareness Campaigns

Informing at-risk groups and healthcare providers about sporotrichosis can help with early recognition and prevention. Strategies include:

  • Public awareness campaigns targeting farmers, gardeners, and pet owners in high-risk areas.
  • Veterinary education to help animal healthcare workers identify and manage feline sporotrichosis.
  • Healthcare training for doctors to recognize sporotrichosis symptoms and improve early diagnosis.

Surveillance and Reporting

Tracking sporotrichosis cases helps public health authorities detect outbreaks and implement control measures. Key efforts include:

  • Mandatory reporting in high-risk regions to monitor cases and trends.
  • Epidemiological studies to understand risk factors and improve prevention efforts.
  • International collaboration to share data and best practices in managing sporotrichosis.

Living with Sporotrichosis

A sporotrichosis diagnosis can be challenging, especially for those with long-term infections or systemic cases. Understanding patient experiences and coping strategies can help individuals navigate the condition with confidence. This part highlights real-life experiences, clinical cases, and strategies for emotional and mental well-being.

Patient Experiences and Case Studies

Hearing from individuals who have faced sporotrichosis can provide comfort and insight. While some cases are mild and resolved with treatment, others require ongoing care and lifestyle adjustments.

Personal Anecdotes

Many patients with sporotrichosis face delayed diagnosis because the infection is often mistaken for a bacterial issue. Treatment can be lengthy, requiring patience and consistency. The condition may also impact daily life, causing discomfort and self-consciousness about visible lesions. 

Clinical Case Studies

Clinical cases highlight the varied presentations of sporotrichosis. One case involved a gardener who developed ulcers on his hands after pruning roses and was successfully treated with itraconazole over four months. 

Another involved a woman with diabetes who developed lung involvement and required hospitalization and intravenous antifungals. These cases show the importance of early diagnosis and tailored treatment.

Coping Strategies

Emotional and social support play a crucial role in recovery. Patients benefit from support networks, including family, friends, healthcare providers, and online support groups. These connections provide encouragement and practical assistance during treatment.

Mental Health Considerations

Living with sporotrichosis can be stressful, leading to anxiety or depression. Coping strategies include seeking counseling, practicing self-care, and staying informed about the condition. Combining medical care with emotional support helps patients maintain a good quality of life and work toward recovery.

[signup]

Key Takeaways

  • Sporotrichosis is a fungal infection caused by Sporothrix schenckii, commonly contracted through minor cuts or scratches while handling plants, soil, or animals, and is more prevalent in tropical and subtropical regions.
  • It primarily affects the skin (cutaneous form) but can spread to lymphatic channels (lymphocutaneous form) or internal organs (systemic form) in severe cases, especially in immunocompromised individuals.
  • Early symptoms include painless bumps that can ulcerate and spread along lymphatic pathways, while severe forms may impact the lungs, bones, joints, or central nervous system.
  • Diagnosis relies on laboratory tests such as fungal cultures and microscopy, with imaging techniques used for systemic involvement, and accurate diagnosis is crucial due to symptom similarities with other conditions.
  • Treatment typically involves antifungal medications like itraconazole, with more severe cases requiring amphotericin B, and prevention focuses on protective gear for at-risk populations, proper wound care, and public health education.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Ar Kar Aung, Bing Mei Teh, McGrath, C., & Thompson, P. J. (2013). Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes. 51(5), 534–544. https://doi.org/10.3109/13693786.2012.751643

Barros, M. B. de L., Paes, R. de A., & Schubach, A. O. (2011). Sporothrix schenckii and Sporotrichosis. Clinical Microbiology Reviews, 24(4), 633–654. https://doi.org/10.1128/CMR.00007-11

Batista-Duharte, A., Pereira, S. A., Saraiva, F., Fuentes, D. P., Gutierrez-Galhardo, M. C., & Carlos, I. Z. (2015). Therapeutic and Prophylactic Tools for Sporotrichosis: Current Strategies and Future Tendencies. Springer EBooks, 147–177. https://doi.org/10.1007/978-3-319-11912-0_9

Bryant, A. (2024, October 18). Lab Tests for Patients With Edema. Rupa Health. https://www.rupahealth.com/post/lab-tests-for-patients-with-edema

CDC. (2024a, May 13). Clinical Overview of Sporotrichosis. Sporotrichosis. https://www.cdc.gov/sporotrichosis/hcp/clinical-overview/index.html

CDC. (2024b, May 14). Sporotrichosis Basics. Sporotrichosis. https://www.cdc.gov/sporotrichosis/about/index.html

Chakrabarti, A., Bonifaz, A., Gutierrez-Galhardo, M. C., Mochizuki, T., & Li, S. (2015). Global epidemiology of sporotrichosis. Medical Mycology, 53(1), 3–14. https://doi.org/10.1093/mmy/myu062

Cloyd, J. (2025, February 7). Addressing Lingering Cough. Rupa Health. https://www.rupahealth.com/post/addressing-lingering-cough

Drageset, J. (2021). Social Support (G. Haugan & M. Eriksson, Eds.). PubMed; Springer. https://www.ncbi.nlm.nih.gov/books/NBK585650/

Fichman, V., Mota-Damasceno, C. G., Procópio-Azevedo, A. C., Almeida-Silva, F., de Macedo, P. M., Medeiros, D. M., Astacio, G. S.-M., Zancopé-Oliveira, R. M., Almeida-Paes, R., Freitas, D. F. S., & Gutierrez-Galhardo, M. C. (2022). Pulmonary Sporotrichosis Caused by Sporothrix brasiliensis: A 22-Year, Single-Center, Retrospective Cohort Study. Journal of Fungi, 8(5), 536. https://doi.org/10.3390/jof8050536

Fichman, V., Saraiva, F., Carlos, A., Valls, R., Luiz, A., Cláudia Maria Valete-Rosalino, Marques, P., Andréa Gina Varon, Helena, M., Almeida-Silva, F., Rosely Maria Zancopé-Oliveira, Raquel, Almeida-Paes, R., & Maria Clara Gutierrez-Galhardo. (2022). Severe Sporotrichosis Treated with Amphotericin B: A 20-Year Cohort Study in an Endemic Area of Zoonotic Transmission. Journal of Fungi, 8(5), 469–469. https://doi.org/10.3390/jof8050469

Gull, T. (2023, April 7). Sporotrichosis in Animals. MSD Veterinary Manual. https://www.msdvetmanual.com/infectious-diseases/fungal-infections/sporotrichosis-in-animals

Kurn, H., & Wadhwa, R. (2021). Itraconazole. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557874/

Mahajan, V. K. (2014). Sporotrichosis: An Overview and Therapeutic Options. Dermatology Research and Practice, 2014(2014). https://doi.org/10.1155/2014/272376

Maholy, N. (2023, May 10). A Functional Medicine Immune Support Protocol. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-immune-support-protocol

Martínez-Herrera, E., Arenas, R., Hernández-Castro, R., Frías-De-León, M. G., & Rodríguez-Cerdeira, C. (2021). Uncommon Clinical Presentations of Sporotrichosis: A Two-Case Report. Pathogens, 10(10), 1249. https://doi.org/10.3390/pathogens10101249

Maxfield, L., Preuss, C. V., & Bermudez, R. (2020). Terbinafine. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545218/

Neibling, K. (2023, February 27). Integrative medicine treatment for headaches. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches

Ngan, V. (2005). Sporotrichosis | DermNet NZ. Dermnetnz.org. https://dermnetnz.org/topics/sporotrichosis

Noor, A., & Preuss, C. V. (2019, September 2). Antifungal membrane function inhibitors (amphotericin B). Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482327/

Oliveira, M. M. E., Almeida-Paes, R., Gutierrez-Galhardo, M. C., & Zancope-Oliveira, R. M. (2014). Molecular identification of the Sporothrix schenckii complex. Revista Iberoamericana de Micología, 31(1), 2–6. https://doi.org/10.1016/j.riam.2013.09.008

Orofino-Costa, R., de Macedo, P. M., Rodrigues, A. M., & Bernardes-Engemann, A. R. (2017). Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. Anais Brasileiros de Dermatologia, 92(5), 606–620. https://doi.org/10.1590/abd1806-4841.2017279

Patel, R., Busby, L. P., & Motamedi, D. (2019). Delayed Diagnosis in a Case of Smoldering Sporotrichal Monoarthropathy. Journal of Radiology Case Reports, 13(1). https://doi.org/10.3941/jrcr.v13i1.3520

Preston, J. (2023, December 18). Functional Medicine Strategies for Managing Joint Pain in Cold Weather. Rupa Health. https://www.rupahealth.com/post/functional-medicine-strategies-for-managing-joint-pain-in-cold-weather

Queiroz-Telles, F., Bonifaz, A., Cognialli, R., Lustosa, B. P. R., Vicente, V. A., & Ramírez-Marín, H. A. (2022). Sporotrichosis in Children: Case series and Narrative Review. Current Fungal Infection Reports. https://doi.org/10.1007/s12281-022-00429-x

Queiroz-Telles, F., Buccheri, R., & Benard, G. (2019). Sporotrichosis In Immunocompromised Hosts. Journal of Fungi, 5(1), 8. https://doi.org/10.3390/jof5010008

Queiroz-Tellez, F., Bonifaz, A., Rossow, J., & Chindamporn, A. (2021). Sporothrix and Sporotrichosis. Www.sciencedirect.com. https://doi.org/10.1016/B978-0-12-818731-9.00046-X

Ramos, V., Astacio, G. S-M., do Valle, A. C. F., de Macedo, P. M., Lyra, M. R., Almeida-Paes, R., Oliveira, M. M. E., Zancopé-Oliveira, R. M., Brandão, L. G. P., Quintana, M. S. B., Gutierrez-Galhardo, M. C., & Freitas, D. F. S. (2021). Bone sporotrichosis: 41 cases from a reference hospital in Rio de Janeiro, Brazil. PLOS Neglected Tropical Diseases, 15(3), e0009250. https://doi.org/10.1371/journal.pntd.0009250

Reed, K. D., Moore, F. M., Geiger, G. E., & Stemper, M. E. (1993). Zoonotic Transmission of Sporotrichosis: Case Report and Review. Clinical Infectious Diseases, 16(3), 384–387. https://doi.org/10.1093/clind/16.3.384

Rodrigues, A. M., Gonçalves, S. S., de Carvalho, J. A., Borba-Santos, L. P., Rozental, S., & Camargo, Z. P. de. (2022). Current Progress on Epidemiology, Diagnosis, and Treatment of Sporotrichosis and Their Future Trends. Journal of Fungi, 8(8), 776. https://doi.org/10.3390/jof8080776

Rossow, J. A., Queiroz-Telles, F., Caceres, D. H., Beer, K. D., Jackson, B. R., Pereira, J. G., Ferreira Gremião, I. D., & Pereira, S. A. (2020). A One Health Approach to Combatting Sporothrix brasiliensis: Narrative Review of an Emerging Zoonotic Fungal Pathogen in South America. Journal of Fungi, 6(4), 247. https://doi.org/10.3390/jof6040247

Rufino, R., Marques, B. L., & Costa, C. H. (2013). Rose Gardener’s disease. Thorax, 68(6), 602. https://doi.org/10.1136/thoraxjnl-2012-202827

Saeed, L., Weber, R. J., Puryear, S. B., Bahrani, E., Peluso, M. J., Babik, J. M., Haemel, A., & Coates, S. J. (2019). Disseminated Cutaneous and Osteoarticular Sporotrichosis Mimicking Pyoderma Gangrenosum. Open Forum Infectious Diseases, 6(10). https://doi.org/10.1093/ofid/ofz395

Schubach, A., Schubach, T. M. P., Barros, M. B. de L., & Wanke, B. (2005). Cat-transmitted Sporotrichosis, Rio de Janeiro, Brazil. Emerging Infectious Diseases, 11(12), 1952–1954. https://doi.org/10.3201/eid1112.040891

Sendrasoa, F. A., Ranaivo, I. M., Sata, M., Razanakoto, N. H., Andrianarison, M., Ratovonjanahary, V., Raharolahy, O., Rakotoarisaona, M., Rasamoelina, T., Andrianarivelo, M. R., Ramarozatovo, L. S., & Rabenja, F. R. (2021). Osteoarticular sporotrichosis in an immunocompetent patient. Medical Mycology Case Reports, 32, 50–52. https://doi.org/10.1016/j.mmcr.2021.03.007

Sharma, B., Sharma, A. K., & Sharma, U. (2022). Sporotrichosis: a Comprehensive Review on Recent Drug-Based Therapeutics and Management. Current Dermatology Reports. https://doi.org/10.1007/s13671-022-00358-5

Sizar, O., & Talati, R. (2020). Sporotrichosis. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532255/

Sporotrichosis | 5-Minute Clinical Consult. (2025). Unboundmedicine.com. https://www.unboundmedicine.com/5minute/view/5-Minute-Clinical-Consult/816093/all/Sporotrichosis

Sporotrichosis Information | Mount Sinai - New York. (n.d.). Mount Sinai Health System. https://www.mountsinai.org/health-library/diseases-conditions/sporotrichosis

Sporotrichosis Treatment, Fungal Infection Pictures, Symptoms, Diagnosis. (n.d.). EMedicineHealth. https://www.emedicinehealth.com/sporotrichosis/article_em.htm

Sporotrichosis: Background, Pathophysiology, Epidemiology. (2020). EMedicine. https://emedicine.medscape.com/article/228723-overview

Sporotrichosis: Causes, Symptoms, and Treatment. (2025). Medicoverhospitals.in. https://www.medicoverhospitals.in/diseases/sporotrichosis/

Sweetnich, J. (2023, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Tai, F., Jakubovic, H., Alabdulrazzaq, S., & Alavi, A. (2020). A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report. SAGE Open Medical Case Reports, 8, 2050313X2091960. https://doi.org/10.1177/2050313x20919600

Trung, V., & Bajaj, T. (2024, August 11). Ibuprofen. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK542299/

UK. (2024, January 17). HAIRS risk statement: sporotrichosis. GOV.UK. https://www.gov.uk/government/publications/hairs-risk-statement-sporotrichosis/hairs-risk-statement-sporotrichosis

University of Michigan. (2020). Protective equipment for working with animals | environment, health & safety. Umich.edu. https://ehs.umich.edu/research-clinical/animals/protective-equipment/

Vergidis, P. (2023, September). Sporotrichosis - Infectious Diseases. MSD Manual Professional Edition. https://www.msdmanuals.com/professional/infectious-diseases/fungi/sporotrichosis

Viviany Araujo Mesquita, Sinesio Talhari, André Luiz Leturiondo, Guilherme, Moreira, E., Lemos, S., Cristina, Zeli, M., Cruz, S., Juliana, Helio Amante Miot, Talhari, C., & Valderiza Lourenço Pedrosa. (2024). Zoonotic Sporotrichosis outbreak: Emerging public health threat in the Amazon State, Brazil. PLoS Neglected Tropical Diseases, 18(7), e0012328–e0012328. https://doi.org/10.1371/journal.pntd.0012328

Wilson, E. (2024, December 19). Low-Grade Fever: Causes, Symptoms, and Management. Rupa Health. https://www.rupahealth.com/post/low-grade-fever-causes-symptoms-and-management

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Infections
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.